Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis

NCT00276757 is registered in ClinicalTrials.gov with Histiocyte Society as lead sponsor.

NCT NCT00276757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Protocol of the Third International Study For Langerhans Cell Histiocytosis
Lead sponsor
Histiocyte Society
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2001
Completion date
June 30, 2013
Enrollment
376 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

childhood langerhans cell histiocytosis